Development Level

Tclin 5 | 602
Tbio 2 | 10,625
Tchem 2 | 1,890

IMPC Term

abnormal behavioral response t... 2 | 52
preweaning lethality, incomple... 2 | 260
decreased anxiety-related resp... 1 | 12
decreased total body fat amoun... 1 | 186
immune system phenotype 1 | 17
increased lean body mass 1 | 107

Disease

Schizophrenia 6 | 501
glioblastoma 6 | 5,572
psoriasis 6 | 6,685
atypical teratoid / rhabdoid tumor 5 | 4,369
medulloblastoma, large-cell 5 | 6,234
osteosarcoma 5 | 7,933
Alcohol dependence 4 | 107
Alzheimer's disease 4 | 644
Attention deficit hyperactivity disorder 4 | 156
Cocaine-Related Disorders 4 | 88
Epilepsy 4 | 346
Migraine 4 | 79
Toxic encephalopathy 4 | 131
astrocytic glioma 4 | 2,241
ovarian cancer 4 | 8,484
tuberculosis 4 | 1,557
Amnestic disorder 3 | 37
Autistic Disorder 3 | 320
Epilepsy, Temporal Lobe 3 | 23
Major Depressive Disorder 3 | 106
Parkinson's disease 3 | 364
Seizures 3 | 95
Status Epilepticus 3 | 85
Substance abuse 3 | 55
ependymoma 3 | 2,514
invasive ductal carcinoma 3 | 2,950
medulloblastoma 3 | 1,524
oligodendroglioma 3 | 2,849
pilocytic astrocytoma 3 | 3,086
pituitary cancer 3 | 1,972
posterior fossa group A ependymoma 3 | 1,511
primitive neuroectodermal tumor 3 | 3,031
sonic hedgehog group medulloblastoma 3 | 1,482
subependymal giant cell astrocytoma 3 | 2,287
Anxiety disorder 2 | 22
Atrial Fibrillation 2 | 110
Breast cancer 2 | 3,094
Cancer 2 | 2,346
Carcinoma 2 | 2,147
Chemotherapy-induced nausea and vomiting 2 | 18
Chronic obstructive pulmonary disease 2 | 146
Fever 2 | 34
Fragile X syndrome 2 | 31
Gastroesophageal reflux disease 2 | 37
Huntington's disease 2 | 72
Hypotension 2 | 53
Multiple Sclerosis 2 | 498
Pain 2 | 70
Pain agnosia 2 | 99
Personality disorder 2 | 25
Substance-Related Disorders 2 | 114
adult high grade glioma 2 | 2,148
aldosterone-producing adenoma 2 | 664
astrocytoma 2 | 1,493
colon cancer 2 | 1,475
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
malignant mesothelioma 2 | 3,162
pancreatic cancer 2 | 2,300
pediatric high grade glioma 2 | 2,712
Acquired immunodeficiency syndrome 1 | 164
Anorexia 1 | 15
Anxiety Disorders 1 | 37
Asthma management 1 | 20
Bradycardia 1 | 24
Bruxism 1 | 19
Cardiac Arrhythmia 1 | 20
Catalepsy 1 | 15
Chronic idiopathic constipation 1 | 3
Cluster headache syndrome 1 | 8
Common cold 1 | 63
Congenital adrenal hyperplasia 1 | 74
Constipation 1 | 43
Diabetic Neuropathies 1 | 13
Diarrhea 1 | 155
Disuse amblyopia 1 | 3
Drug psychosis 1 | 6
Dyspepsia 1 | 34
Fibroma 1 | 16
Generalized anxiety disorder 1 | 29
Hepatic encephalopathy 1 | 25
Hypoactive sexual desire disorder 1 | 9
Ileus 1 | 11
Irritable bowel syndrome 1 | 59
Irritable bowel syndrome characterized by constipation 1 | 3
Liver Cirrhosis 1 | 101
Liver Cirrhosis, Experimental 1 | 108
Memory Disorders 1 | 36
Motion sickness 1 | 32
Nicotine dependence 1 | 53
Pancreatitis 1 | 97
Psoriatic arthritis 1 | 83
Psychoses, Substance-Induced 1 | 17
Psychotic Disorders 1 | 20
Pulmonary emphysema 1 | 34
Pulmonary function (finding) 1 | 33
Pylorospasm 1 | 2
Rhabdomyosarcoma 1 | 29
Substance Withdrawal Syndrome 1 | 52
Sudden infant death syndrome 1 | 33
obsessive-compulsive disorder 1 | 34

Tissue

Cardiovascular System 9 | 17,958
Endocrine System 9 | 18,512
Female tissues 9 | 18,647
Nervous System 9 | 18,561
Urinary Tract 9 | 18,444
Blood and immune system 8 | 17,995
Digestive Tract 8 | 18,473
Liver and Pancreas 8 | 18,136
Male tissues 8 | 17,969
Respiratory system 8 | 17,484
Skin and soft tissues 7 | 18,115

Target Family

GPCR 6 | 406
Enzyme 2 | 4,146
Non-IDG 1 | 11,971

Grant Application

1ZIAMH002793-09 9 | 9
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
cAMP-specific 3',5'-cyclic phosphodiesterase 4A PDE4A Tclin Enzyme -3.02895 1167.8 276
Putative peripheral benzodiazepine receptor-related protein TSPO Tbio Non-IDG -3.29377 2078.3 186
5-hydroxytryptamine receptor 4 HTR4 Tclin GPCR -2.86621 789.6 230
Metabotropic glutamate receptor 5 GRM5 Tchem GPCR -3.08324 1295.5 348
Glycerol-3-phosphate phosphatase PGP Tbio Enzyme -1.98314 94.7 69
Cannabinoid receptor 1 CNR1 Tclin GPCR -3.68588 5020.0 389
5-hydroxytryptamine receptor 1A HTR1A Tclin GPCR -3.67081 4839.2 234
Metabotropic glutamate receptor 1 GRM1 Tchem GPCR -3.02875 1071.7 407
5-hydroxytryptamine receptor 1B HTR1B Tclin GPCR -3.01948 1050.4 200